Dr Gopal on Treatment Selection in Second-Line R/R mUC
Nikhil A. Gopal, MD, assistant professor, urology, assistant professor, College of Medicine – Memphis, Department of Urology, The University of Tennessee Health Science Center, discusses treatment selection in the second line and beyond for patients with relapsed/refractory metastatic urothelial cancer.